ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

Denman Hammond, NCCF Founder, Receives Award.

November 17, 2000

Witnesses Seek 15% Boost For NCI In 1998 as First Step to 100% Raise Over 5 Years

May 9, 1997

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

The First BRCA1 Test Hits The Market; Are Oncologists, Patients Ready?

January 26, 1996

NCI, Advisers Lean To Smaller Increases For R01a, Philosophy Of Spreading Money Among More Grants

January 15, 1982

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997